Conflict of Interest Disclosures for Society Leadership
President
Mohandas Narla, DSc, New York Blood Center
Consultancy for Forma Therapeutics and New York Blood Center; Honoraria from National Institutes of Health; Membership on a Board or Advisory Committee for Canadian Blood Services; Patents & Royalties from Lawrence Berkeley National Laboratory and UpToDate; Research Funding from National Institutes of Health.
President-Elect
Belinda Avalos, MD, Atrium Health Levine Cancer Institute
Membership on a Board or Advisory Committee for Juno CAR-T cell Advisory Board; and Patents & Royalties from BMJ Best Practice.
Vice President
Robert Negrin, MD, Stanford University
Consultancy and Equity Ownership (multiple companies), Membership on a Board or Advisory Committee DSMB for a clinical study of CAR T cells.
Secretary
Cynthia E. Dunbar, MD, National Institutes of Health
Research funding from Be Bio, Disc Medicine, and Novartis; Honoraria from UpToDate.
Treasurer
Joseph R. Mikhael, MD, FRCPC, MEd, Translational Genomics Research Institute
Honoraria from Amgen, GSK, Janssen, Karyopharm, Sanofi, and Takeda; and Consultancy for BMS and Pfizer.
Blood Editor-in-Chief
Nancy Berliner, MD, Brigham and Women's Hospital
Honoraria from UpToDate.
Blood Advances Editor-in-Chief
Catherine M. Bollard, MD, Children's National Medical Center
Equity Ownership of Caballeta Bio, Mana Therapeutics, Neximmune, and Repertoire; Membership on a Board or Advisory Committee for Caballeta Bio, Catamaran Bio, Mana Therapeutics, and SOBI; Patents & Royalties from Mana Therapeutics; Consultancy for Neogene and Roche; and Honoraria from Neogene, Roche, and SOBI.
Executive Director
Martha Liggett, American Society of Hematology
Indicated no conflicts of interest.
Deputy Executive Director
Matthew Gertzog, American Society of Hematology
Equity ownership of Amgen.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission